Strata Oncology
The company said the results highlight precision oncology implementation challenges and its test's ability to help overcome these issues.
Strata Oncology Raises $90M in Series C Financing
The firm said it will use the proceeds to accelerate development of its MRD assay for early-stage cancers and its treatment selection tests for solid tumors.
Strata Oncology, Pfizer Partner to Explore New Biomarker Indications for FDA-Approved Drugs
Pfizer is the first drugmaker to join the Strata PATH platform trial and will contribute drugs to advanced cancer patients in four study arms.